Cariprazine, sold under the brand names Vraylar in the United States and Reagila in Europe, is an atypical antipsychotic.It acts primarily as a D3 receptor and D2 receptor partial agonist, with high selectivity for the D3receptor
Cariprazine (trade name: Reagila) has been approved in Germany since July 2017 for the treatment of schizophrenia in adults.
Rasso Swiss Pharma is a Reagila (Cariprazine) wholesaler distributor, supplier.
<< Back to products